MENU
+Compare
GPCR
Stock ticker: NASDAQ
AS OF
Sep 3, 04:59 PM (EDT)
Price
$19.71
Change
-$0.37 (-1.84%)
Capitalization
1.16B

GPCR Structure Therapeutics Forecast, Technical & Fundamental Analysis

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more

GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GPCR with price predictions
Sep 02, 2025

GPCR sees its Stochastic Oscillator climbs out of oversold territory

On September 02, 2025, the Stochastic Oscillator for GPCR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 38 instances where the indicator left the oversold zone. In of the 38 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GPCR's RSI Oscillator exited the oversold zone, of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 02, 2025. You may want to consider a long position or call options on GPCR as a result. In of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GPCR just turned positive on August 11, 2025. Looking at past instances where GPCR's MACD turned positive, the stock continued to rise in of 27 cases over the following month. The odds of a continued upward trend are .

GPCR moved above its 50-day moving average on August 28, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GPCR crossed bullishly above the 50-day moving average on August 26, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GPCR advanced for three days, in of 136 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GPCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GPCR broke above its upper Bollinger Band on August 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GPCR entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.498) is normal, around the industry mean (19.852). P/E Ratio (0.000) is within average values for comparable stocks, (51.814). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.136). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.082).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GPCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GPCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GPCR is expected to report earnings to fall 25.00% to -27 cents per share on November 12

Structure Therapeutics GPCR Stock Earnings Reports
Q3'25
Est.
$-0.27
Q2'25
Missed
by $0.10
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.07
The last earnings report on August 06 showed earnings per share of -36 cents, missing the estimate of -25 cents. With 5.41M shares outstanding, the current market capitalization sits at 1.16B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 457-1978
Employees
93
Web
https://www.structuretx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBALX17.12-0.06
-0.35%
Weitz Conservative Allocation-Inv Cl
PEUCX40.94-0.16
-0.39%
Principal Equity Income C
MAIFX10.26-0.10
-0.97%
MoA International Fund
WPASX54.39-0.55
-1.00%
AB Concentrated Growth A
PGKCX26.92-0.31
-1.14%
PGIM Jennison Technology C

GPCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+4.04%
CRNX - GPCR
43%
Loosely correlated
+7.45%
CLDX - GPCR
42%
Loosely correlated
-0.09%
APGE - GPCR
41%
Loosely correlated
+4.10%
VKTX - GPCR
40%
Loosely correlated
+1.63%
SYRE - GPCR
40%
Loosely correlated
+0.85%
More